StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
228
This month
1
This year
33
Publishing Date
2024 - 03 - 13
2
2024 - 03 - 05
2
2024 - 02 - 28
2
2024 - 02 - 01
2
2024 - 01 - 17
2
2024 - 01 - 12
2
2023 - 12 - 14
3
2023 - 11 - 03
2
2023 - 11 - 01
2
2023 - 09 - 29
2
2023 - 09 - 22
2
2023 - 08 - 28
2
2023 - 08 - 25
5
2023 - 08 - 22
2
2023 - 07 - 21
2
2023 - 07 - 05
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 05 - 17
2
2023 - 04 - 25
2
2023 - 03 - 20
2
2023 - 03 - 15
2
2023 - 02 - 24
3
2023 - 02 - 20
2
2023 - 02 - 17
3
2023 - 02 - 16
2
2023 - 02 - 13
2
2023 - 01 - 26
2
2023 - 01 - 25
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
3
2022 - 12 - 01
2
2022 - 11 - 21
2
2022 - 09 - 28
2
2022 - 09 - 20
1
2022 - 09 - 19
2
2022 - 09 - 16
2
2022 - 09 - 14
1
2022 - 09 - 13
2
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 05
2
2022 - 09 - 02
1
2022 - 08 - 29
1
2022 - 08 - 26
1
2022 - 08 - 25
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 19
1
2022 - 08 - 16
1
2022 - 08 - 12
1
2022 - 08 - 10
1
2022 - 08 - 08
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 25
2
2022 - 07 - 21
1
2022 - 07 - 19
1
Sector
Commercial services
1
Consumer non-durables
5
Consumer services
1
Distribution services
1
Electronic technology
5
Finance
1
Health services
3
Health technology
228
Information
1
Manufacturing
25
N/a
15
Process industries
5
Producer manufacturing
8
Professional, scientific, and technical services
2
Technology services
3
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
86
Earnings
18
Europe
15
Expansion
11
Expected
35
Eye
15
Fda
23
Financial
24
Global
228
Growing
43
Growth
236
Health
19
Immunotherapy
11
Infection
9
Key
9
Kisqali
11
Leukemia
10
Liver
11
Market
593
N/a
948
Novartis
134
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
10
Sclerosis
13
Set
16
Study
15
T-cell
11
Technology
12
Therapeutics
110
Therapy
65
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
3m company
5
Abbott laboratories
35
Abbvie inc.
50
Adaptimmune therapeutics plc
3
Aerie pharmaceuticals, inc.
2
Agilent technologies, inc.
2
Albemarle corporation
2
Alkermes plc
2
Allscripts healthcare solutions, inc.
2
Amgen inc.
41
Astellas pharma inc
11
Astrazeneca plc
44
Autolus therapeutics plc
2
Bausch health companies inc.
14
Baxter international inc.
5
Becton, dickinson and company
5
Bio-rad laboratories, inc.
3
Biogen inc.
9
Biontech se
3
Boston scientific corporation
3
Bristol-myers squibb company
34
Bruker corporation
2
Csl ltd
4
Danaher corporation
7
Eli lilly and company
50
Endo international plc
7
General electric company
3
Genmab a/s
2
Gilead sciences, inc.
15
Glaxosmithkline plc
70
Hologic, inc.
2
Idex corporation
2
Illumina, inc.
4
Ionis pharmaceuticals, inc.
2
Iridex corporation
2
Jazz pharmaceuticals plc
2
Johnson & johnson
82
Koninklijke philips n.v.
5
Mallinckrodt plc
3
Medtronic plc
6
Novartis ag
228
Novo nordisk a/s
15
Opko health, inc.
3
Orasure technologies, inc.
2
Perrigo company
2
Pfizer, inc.
21
Precision biosciences, inc.
3
Prestige consumer healthcare inc.
2
Qiagen n.v.
2
Quidel corporation
2
Reckitt benckiser group plc
3
Regeneron pharmaceuticals, inc.
5
Regenxbio inc.
2
Sanofi
81
Takeda pharmaceutical company limited
15
Terumo corp
5
Teva pharmaceutical industries ltd
44
Thermo fisher scientific inc
13
Ucb s.a.
3
Viatris inc.
18
Symbols
A
88
AAPL
138
ABB
210
ABBNY
86
ABBV
113
ABLZF
210
ABT
349
AMGN
83
ARVL
147
AZN
108
AZNCF
104
BDX
159
BEEM
123
BIO
110
BSX
116
CSCO
134
DD
86
DHR
163
DNZOF
113
DNZOY
113
EMN
79
ERIC
183
FNCTF
218
GE
197
GLAXF
159
GOOG
92
GOOGL
91
GSK
159
HON
288
IBM
97
IFNNF
100
IFNNY
100
INTC
184
JNJ
422
LLY
149
LMT
147
MDT
223
MMM
215
MS
246
MSFT
258
NIPNF
109
NOC
112
NVDA
90
NVS
229
NVSEF
228
ORCL
207
PCRFF
184
PCRFY
184
PHG
200
QGEN
77
SAP
172
SAPGF
171
SNY
356
SNYNF
356
SPGI
149
SYK
100
TEVJF
111
TMO
281
TRUMF
82
TRUMY
82
Exchanges
Nasdaq
228
Nyse
228
Crawled Date
2024 - 03 - 13
2
2024 - 03 - 05
2
2024 - 02 - 28
2
2024 - 02 - 01
2
2024 - 01 - 17
2
2024 - 01 - 12
2
2023 - 12 - 14
2
2023 - 11 - 03
2
2023 - 11 - 01
2
2023 - 09 - 29
2
2023 - 09 - 22
2
2023 - 08 - 28
2
2023 - 08 - 25
5
2023 - 08 - 22
2
2023 - 07 - 21
2
2023 - 06 - 29
2
2023 - 06 - 23
2
2023 - 06 - 08
2
2023 - 04 - 28
2
2023 - 04 - 25
2
2023 - 03 - 15
2
2023 - 02 - 24
3
2023 - 02 - 21
2
2023 - 02 - 17
3
2023 - 02 - 16
2
2023 - 02 - 14
2
2023 - 01 - 27
2
2023 - 01 - 25
2
2023 - 01 - 16
3
2023 - 01 - 03
2
2022 - 12 - 30
3
2022 - 12 - 01
2
2022 - 11 - 21
2
2022 - 09 - 28
2
2022 - 09 - 23
1
2022 - 09 - 22
1
2022 - 09 - 20
1
2022 - 09 - 19
2
2022 - 09 - 16
2
2022 - 09 - 14
1
2022 - 09 - 13
2
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 05
2
2022 - 09 - 02
1
2022 - 08 - 29
1
2022 - 08 - 26
1
2022 - 08 - 25
1
2022 - 08 - 23
1
2022 - 08 - 22
1
2022 - 08 - 19
1
2022 - 08 - 16
1
2022 - 08 - 12
1
2022 - 08 - 10
1
2022 - 08 - 08
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 25
2
2022 - 07 - 21
1
2022 - 07 - 19
1
Crawled Time
00:00
14
00:20
3
01:00
15
02:00
8
03:00
5
04:00
2
04:20
4
05:00
1
06:00
2
09:00
4
10:00
8
11:00
11
11:01
1
12:00
7
12:20
1
13:00
4
14:00
4
14:20
1
14:30
1
14:49
1
15:00
8
15:20
3
15:30
5
16:00
14
16:20
1
17:00
20
18:00
16
19:00
14
20:00
15
21:00
10
22:00
14
23:00
11
Source
www.globenewswire.com
3
www.prnewswire.com
225
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Global
symbols :
Nvsef
save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-1.6%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
2.1%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.885
1.57%
1.54%
360K
|
Health Technology
|
-12.36%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.54
-1.48%
-1.51%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$289.67
3.83%
5.3K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-4.25%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-0.6%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-1.16%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.47%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-5.58%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-6.02%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-7.72%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-5.03%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-1.36%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.12%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
-11.05%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.95%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-3.27%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.01%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.61%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.13%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-7.46%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-3.27%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.01%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.61%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.13%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-7.46%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.27%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.33%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.16%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.82%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-6.26%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-10.85%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.79%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.95%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-0.35%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published:
2024-03-05
(Crawled : 05:00)
- prnewswire.com
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-5.72%
|
O:
-0.09%
H:
0.86%
C:
0.6%
DGX
|
News
|
$136.7
5.08%
0.0%
2.1M
|
Health Services
|
3.81%
|
O:
0.38%
H:
0.69%
C:
-1.01%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.06%
|
O:
0.32%
H:
0.22%
C:
-0.2%
BIO
|
$285.28
1.84%
0.0%
230K
|
Health Technology
|
-16.3%
|
O:
-0.53%
H:
1.08%
C:
-0.59%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-9.65%
|
O:
1.6%
H:
0.0%
C:
0.0%
QDEL
|
News
4
|
$40.43
3.45%
3.34%
1.2M
|
Health Technology
|
-11.84%
|
O:
0.18%
H:
1.13%
C:
-3.31%
report
respiratory
global
rsv
virus
diagnostics
growth
market
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published:
2024-03-05
(Crawled : 01:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.06%
|
O:
0.32%
H:
0.22%
C:
-0.2%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.03%
|
O:
-0.24%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.54%
|
O:
1.17%
H:
0.0%
C:
0.0%
report
sciences
global
key
market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.935
3.16%
3.06%
5M
|
Manufacturing
|
-10.17%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.12%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.81%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.09%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 - Focus on United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India
Published:
2024-02-28
(Crawled : 03:00)
- prnewswire.com
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-14.97%
|
O:
-0.15%
H:
2.57%
C:
-6.96%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.12%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.81%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-9.39%
|
O:
1.12%
H:
0.52%
C:
0.47%
report
india
global
market
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
-15.79%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
0.59%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.06%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.96%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.74%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.22%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
7.83%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-4.99%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.41%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.4%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$109.685
0.79%
0.78%
380K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published:
2024-02-16
(Crawled : 23:00)
- prnewswire.com
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$80.76
0.19%
0.0%
940K
|
Health Technology
|
Email alert
Add to watchlist
STAA
|
$48.28
3.72%
3.48%
750K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
report
global
diabetes
market
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.488
-17.59%
1.7K
|
Health Technology
|
-55.26%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-4.41%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.94
0.79%
52K
|
Manufacturing
|
-54.46%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-4.88%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.57%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.93%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.51%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published:
2024-02-14
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-2.55%
|
O:
1.95%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-4.32%
|
O:
0.26%
H:
0.87%
C:
0.32%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.06%
|
O:
0.48%
H:
1.56%
C:
1.48%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.26%
|
O:
-0.75%
H:
0.86%
C:
0.41%
biosimilar
report
global
therapy
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.2%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.19%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.35%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.06%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.61%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.7%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
12.64%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.6%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-10.96%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
10.98%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.92%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.18%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-4.75%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.5%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.74%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.4%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
10.41%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.